+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Quinidine Sulfate - Global Strategic Business Report

  • PDF Icon

    Report

  • 175 Pages
  • July 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6105891
The global market for Quinidine Sulfate was estimated at US$1.1 Billion in 2024 and is projected to reach US$1.3 Billion by 2030, growing at a CAGR of 2.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Quinidine Sulfate market.

Global Quinidine Sulfate Market - Key Trends & Drivers Summarized

What Role Does Quinidine Sulfate Play in Modern Cardiovascular Therapies?

Quinidine sulfate has long held its position as a key antiarrhythmic agent, primarily used in the treatment of atrial and ventricular arrhythmias. Derived from the cinchona bark, quinidine works by slowing electrical conduction in the heart, stabilizing rhythm, and preventing recurrent episodes of tachyarrhythmia. In clinical settings, it is most commonly administered orally in sulfate form due to its superior bioavailability and pharmacokinetics. Although its use has declined with the advent of newer antiarrhythmic drugs, it remains an essential agent for niche applications, particularly in patients who demonstrate intolerance or resistance to contemporary alternatives. Its use is also being revisited due to its efficacy in treating Brugada syndrome and certain forms of short QT syndrome.

Healthcare practitioners often prescribe quinidine sulfate in carefully titrated doses, especially for long-term rhythm maintenance therapy in atrial fibrillation patients. The drug is also indicated in the management of malaria caused by Plasmodium falciparum in resistant cases, where other quinine derivatives fail. This duality of use supports its inclusion on the WHO Model List of Essential Medicines, indicating its continued relevance in both cardiovascular and tropical disease pharmacotherapy. Current medical literature highlights its value in pediatric cardiology and rare genetic arrhythmias where precision-based treatment protocols are evolving.

What Are the Key Applications and End-Use Trends Supporting Its Market Relevance?

The global quinidine sulfate market is majorly driven by applications in hospitals, specialty cardiac care centers, and research institutions. The compound is supplied in oral and injectable formats, with the oral sulfate form dominating the outpatient segment. With increasing focus on arrhythmia management, particularly in geriatric patients with multiple comorbidities, the demand for quinidine-based regimens remains relevant. Furthermore, the rising use of pharmacogenomics to identify optimal drug pathways for atrial fibrillation and congenital syndromes has revitalized interest in older antiarrhythmic compounds, especially those with a well-documented safety profile like quinidine.

In terms of end-use dynamics, the compound is witnessing renewed demand in academic research and drug repositioning initiatives. Research efforts are examining the repositioning of quinidine sulfate for neuromuscular diseases such as ALS (Amyotrophic Lateral Sclerosis) and epilepsy, where it modulates sodium channels in unique ways. Veterinary applications are also under investigation, particularly for equine cardiac conditions. Additionally, global health initiatives targeting drug-resistant malaria strains in underdeveloped regions are driving government procurements through public health channels, giving the quinidine sulfate market a broader geographical and therapeutic reach than typically acknowledged.

How Are Regulations and Drug Supply Chains Shaping Market Expansion?

The regulatory landscape governing quinidine sulfate is characterized by stringent quality, dosage, and pharmacovigilance standards. In North America and Europe, its use is tightly controlled, often requiring cardiac monitoring due to the risk of QT prolongation and torsades de pointes. However, these regulations have not dampened its utility, particularly in regions with high incidence of congenital arrhythmias or where alternative therapies are economically unfeasible. Generic manufacturers in India, China, and Eastern Europe have contributed to the global supply chain, making quinidine sulfate accessible in emerging markets while also supporting international aid and health programs.

From a supply chain perspective, the market faces periodic challenges due to reliance on limited active pharmaceutical ingredient (API) suppliers. The extraction of quinidine from natural sources is complex, and synthetic production remains cost-intensive. These factors have contributed to price volatility in recent years. Despite this, government-backed essential medicine programs and inclusion in rare disease reimbursement frameworks in countries like Brazil, Indonesia, and South Africa are keeping the distribution channels active. Partnerships between NGOs and pharmaceutical suppliers are also expanding the footprint of quinidine sulfate into less commercialized, yet clinically dependent, regional markets.

What Is Driving the Growth of the Quinidine Sulfate Market?

The growth in the quinidine sulfate market is driven by several factors, most notably the resurgence in clinical interest for managing genetically triggered arrhythmias and rare cardiac syndromes. Rising incidences of atrial fibrillation globally, especially among aging populations, have created a parallel demand for diverse pharmacologic options beyond contemporary beta-blockers and calcium channel blockers. The renewed emphasis on personalized medicine is also leading to selective re-adoption of quinidine sulfate based on individual patient profiles and genetic markers that favor its efficacy.

Drug repurposing initiatives further support market growth, especially as researchers uncover its off-label potential in treating sodium-channel related neurological conditions. The market is additionally supported by its role in combating drug-resistant malaria in specific geographies, where it remains an effective and essential second-line treatment. Moreover, the cost advantage of quinidine sulfate over newer antiarrhythmic agents in certain public healthcare systems continues to reinforce its usage. With academic trials and institutional research exploring expanded use cases, the global market for quinidine sulfate is expected to maintain steady growth across therapeutic and geographic segments over the coming decade.

Scope Of Study:

The report analyzes the Quinidine Sulfate market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments: Disease Type (Malaria, Arrhythmias, Other Diseases)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Malaria segment, which is expected to reach US$738.7 Million by 2030 with a CAGR of a 2.2%. The Arrhythmias segment is also set to grow at 4.1% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $303.8 Million in 2024, and China, forecasted to grow at an impressive 5.4% CAGR to reach $256.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Quinidine Sulfate Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Quinidine Sulfate Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Quinidine Sulfate Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as ALLURE REMEDIES PVT. LTD., Aurobindo Pharma, Bennet Pharmaceuticals Ltd, Biophore India Pharmaceuticals Pvt. Ltd, Buchler GmbH and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 34 companies featured in this Quinidine Sulfate market report include:

  • ALLURE REMEDIES PVT. LTD.
  • Aurobindo Pharma
  • Bennet Pharmaceuticals Ltd
  • Biophore India Pharmaceuticals Pvt. Ltd
  • Buchler GmbH
  • Cipla Ltd
  • Dr.?Reddy’s Laboratories Ltd
  • Intas Pharmaceuticals
  • Ipca Laboratories Ltd
  • Lark Laboratories India Ltd
  • Merck & Co., Inc.
  • Merck KGaA
  • Mylan N.V. (Viatrus/Mylan)
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Skymax Laboratories
  • Strides Pharma
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Quinidine Sulfate - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Atrial Fibrillation and Cardiac Arrhythmias Drives Demand for Antiarrhythmic Drugs
  • Innovation in Extended-Release Formulations Strengthens Treatment Adherence
  • Growth in Rare Disease Treatment Protocols Throws the Spotlight on Quinidine's Broader Applications
  • Regulatory Reapprovals for Repurposed Molecules Promote Quinidine Use in Orphan Indications
  • Development of Digital Cardiology Platforms Enhances Drug Monitoring Capabilities
  • Increasing Availability of Compounded Quinidine Formulations Boosts Hospital-Based Prescriptions
  • Partnerships With Cardiologists Strengthen Protocol-Based Dosing Adoption
  • Growing Research on Genetic Markers in Drug Metabolism Supports Personalized Dosage Regimens
  • Focus on Drug-Drug Interaction Risk Management Promotes Safer Combination Therapies
  • Expansion of Quinidine Application in Neurological Disorders Broadens Therapeutic Potential
  • Regulatory Guidance on Narrow Therapeutic Index Drugs Drives Monitoring Standards
  • Innovation in Microdose and Pediatric Formulations Supports Specialty Market Penetration
  • Rising Emphasis on Labeling Accuracy and GMP Compliance Fuels Manufacturing Modernization
  • Collaboration With Pharmacovigilance Networks Improves Long-Term Safety Profiling
  • Growth in Availability of Online Pharmacies and Specialty Drug Distributors Enhances Market Reach
  • Entry Into Global Licensing Agreements Strengthens Regional Access Strategies
  • Increasing Interest in Drug Repositioning Accelerates Investment in Quinidine Research
  • Support for Cardiology Clinics and Hospital Networks Boosts Direct Engagement
  • Emergence of Drug Supply Shortage Mitigation Programs Promotes Production Scalability
  • Expansion of Clinical Trial Evidence Base Elevates Prescriber Confidence in Quinidine Use
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Quinidine Sulfate Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Quinidine Sulfate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Quinidine Sulfate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Quinidine Sulfate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Malaria by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Malaria by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Malaria by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Arrhythmias by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Arrhythmias by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Arrhythmias by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Other Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Quinidine Sulfate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 14: USA Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 15: USA Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: USA 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
CANADA
  • TABLE 17: Canada Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 18: Canada Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: Canada 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
JAPAN
  • Quinidine Sulfate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 20: Japan Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 21: Japan Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: Japan 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
CHINA
  • Quinidine Sulfate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 23: China Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 24: China Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: China 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
EUROPE
  • Quinidine Sulfate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 26: Europe Recent Past, Current & Future Analysis for Quinidine Sulfate by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: Europe Historic Review for Quinidine Sulfate by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: Europe 16-Year Perspective for Quinidine Sulfate by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 29: Europe Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: Europe Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: Europe 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
FRANCE
  • Quinidine Sulfate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 32: France Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: France Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: France 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
GERMANY
  • Quinidine Sulfate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 35: Germany Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Germany Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: Germany 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
ITALY
  • TABLE 38: Italy Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Italy Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: Italy 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
UNITED KINGDOM
  • Quinidine Sulfate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 41: UK Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: UK Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: UK 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
SPAIN
  • TABLE 44: Spain Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Spain Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: Spain 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
RUSSIA
  • TABLE 47: Russia Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Russia Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Russia 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
REST OF EUROPE
  • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Rest of Europe Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Rest of Europe 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
ASIA-PACIFIC
  • Quinidine Sulfate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Quinidine Sulfate by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 54: Asia-Pacific Historic Review for Quinidine Sulfate by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: Asia-Pacific 16-Year Perspective for Quinidine Sulfate by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Asia-Pacific Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: Asia-Pacific 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
AUSTRALIA
  • Quinidine Sulfate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 59: Australia Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Australia Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: Australia 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
INDIA
  • Quinidine Sulfate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 62: India Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: India Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: India 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
SOUTH KOREA
  • TABLE 65: South Korea Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: South Korea Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: South Korea 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
REST OF ASIA-PACIFIC
  • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Rest of Asia-Pacific Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
LATIN AMERICA
  • Quinidine Sulfate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 71: Latin America Recent Past, Current & Future Analysis for Quinidine Sulfate by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 72: Latin America Historic Review for Quinidine Sulfate by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Latin America 16-Year Perspective for Quinidine Sulfate by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 74: Latin America Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Latin America Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: Latin America 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
ARGENTINA
  • TABLE 77: Argentina Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Argentina Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: Argentina 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
BRAZIL
  • TABLE 80: Brazil Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Brazil Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: Brazil 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
MEXICO
  • TABLE 83: Mexico Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Mexico Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: Mexico 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
REST OF LATIN AMERICA
  • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Rest of Latin America Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Rest of Latin America 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
MIDDLE EAST
  • Quinidine Sulfate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 89: Middle East Recent Past, Current & Future Analysis for Quinidine Sulfate by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 90: Middle East Historic Review for Quinidine Sulfate by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Middle East 16-Year Perspective for Quinidine Sulfate by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 92: Middle East Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Middle East Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: Middle East 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
IRAN
  • TABLE 95: Iran Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Iran Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Iran 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
ISRAEL
  • TABLE 98: Israel Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Israel Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Israel 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
SAUDI ARABIA
  • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Saudi Arabia Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Saudi Arabia 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
UNITED ARAB EMIRATES
  • TABLE 104: UAE Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UAE Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: UAE 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
REST OF MIDDLE EAST
  • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Rest of Middle East Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: Rest of Middle East 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
AFRICA
  • Quinidine Sulfate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 110: Africa Recent Past, Current & Future Analysis for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Africa Historic Review for Quinidine Sulfate by Disease Type - Malaria, Arrhythmias and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: Africa 16-Year Perspective for Quinidine Sulfate by Disease Type - Percentage Breakdown of Value Sales for Malaria, Arrhythmias and Other Diseases for the Years 2014, 2025 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ALLURE REMEDIES PVT. LTD.
  • Aurobindo Pharma
  • Bennet Pharmaceuticals Ltd
  • Biophore India Pharmaceuticals Pvt. Ltd
  • Buchler GmbH
  • Cipla Ltd
  • Dr.?Reddy’s Laboratories Ltd
  • Intas Pharmaceuticals
  • Ipca Laboratories Ltd
  • Lark Laboratories India Ltd
  • Merck & Co., Inc.
  • Merck KGaA
  • Mylan N.V. (Viatrus/Mylan)
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Skymax Laboratories
  • Strides Pharma
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Table Information